The Condition PCOS is Now Called PMOS

Researchers and clinicians have renamed polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) to better reflect the condition’s broader hormonal and metabolic impacts and improve patient care.

Affecting an estimated 1 in 8 women worldwide, the condition is associated with irregular menstrual cycles, elevated androgen levels, infertility, and increased risk of Type 2 diabetes, heart disease, and stroke. Experts say the previous name contributed to confusion, missed diagnoses, and limited understanding of the disorder beyond ovarian symptoms.

The updated terminology follows 14 years of collaboration among researchers, clinicians, and patients and is intended to support more comprehensive diagnosis and treatment approaches. Learn more from AP here.